• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双膦酸盐治疗相关并发症:颌骨坏死。

Complication related to bisphosphonate therapy: osteonecrosis of the jaw.

作者信息

Lee Jennifer

机构信息

Veterans Affairs Long Beach Healthcare System, 5701 E 7th St, Long Beach, CA 90822, USA.

出版信息

J Infus Nurs. 2009 Nov-Dec;32(6):330-5. doi: 10.1097/NAN.0b013e3181bd5373.

DOI:10.1097/NAN.0b013e3181bd5373
PMID:19918142
Abstract

Bisphosphonates are synthetic analogs of naturally occurring pyrophosphates, and they inhibit osteoclast-mediated bone resorption. They are widely used for the prevention and treatment of osteoporosis, treatment of Paget's disease of bone, management of metastatic cancer in bone, and short-term management of acute hypercalcemia. Osteonecrosis of the jaw is an adverse drug effect of bisphosphonates, and it typically presents as infection and necrotic bone in the mandible or maxilla. This article discusses pharmacology of bisphosphonates and osteonecrosis of the jaw, including its contributing factors, pathophysiology, prevention, and management, as well as appropriate nursing interventions.

摘要

双膦酸盐是天然焦磷酸盐的合成类似物,可抑制破骨细胞介导的骨吸收。它们广泛用于预防和治疗骨质疏松症、治疗骨Paget病、管理骨转移癌以及急性高钙血症的短期管理。颌骨坏死是双膦酸盐的一种药物不良反应,通常表现为下颌骨或上颌骨的感染和坏死骨。本文讨论双膦酸盐的药理学和颌骨坏死,包括其促成因素、病理生理学、预防和管理,以及适当的护理干预措施。

相似文献

1
Complication related to bisphosphonate therapy: osteonecrosis of the jaw.双膦酸盐治疗相关并发症:颌骨坏死。
J Infus Nurs. 2009 Nov-Dec;32(6):330-5. doi: 10.1097/NAN.0b013e3181bd5373.
2
Bisphosphonate-related osteonecrosis of the jaw: an overview.双膦酸盐相关性颌骨坏死:概述。
Ann N Y Acad Sci. 2011 Feb;1218:38-46. doi: 10.1111/j.1749-6632.2010.05768.x. Epub 2010 Sep 28.
3
Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.双膦酸盐相关骨坏死:临床医生患者管理参考
Todays FDA. 2008 Aug;20(8):38-41, 43-6.
4
Osteonecrosis and bisphosphonates in oral and maxillofacial surgery.口腔颌面外科中的骨坏死与双膦酸盐
Oral Maxillofac Surg Clin North Am. 2007 May;19(2):199-206, vi. doi: 10.1016/j.coms.2007.01.005.
5
Bisphosphonates and osteonecrosis of the jaws: science and rationale.双膦酸盐与颌骨骨坏死:科学依据与原理
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Aug;104(2):186-93. doi: 10.1016/j.tripleo.2006.12.004. Epub 2007 Apr 20.
6
[Bisphosphonate-associated osteonecrosis of the jaws. 2. Six case reports].
Ned Tijdschr Tandheelkd. 2007 Oct;114(10):428-31.
7
Postmenopausal females and the link between oral bisphosphonates and osteonecrosis of the jaw: a clinical review.
J Am Acad Nurse Pract. 2010 Oct;22(10):534-9. doi: 10.1111/j.1745-7599.2010.00549.x. Epub 2010 Sep 3.
8
Bisphosphonates and osteonecrosis: potential treatment or serious complication?双膦酸盐与骨坏死:潜在的治疗方法还是严重的并发症?
Orthop Clin North Am. 2009 Apr;40(2):223-34. doi: 10.1016/j.ocl.2008.12.002.
9
Bisphosphonates and osteonecrosis of the jaws.双膦酸盐与颌骨骨坏死
J Dent Educ. 2008 Aug;72(8):919-29.
10
A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.关于口服双膦酸盐治疗的骨质疏松症患者颌骨坏死的文献综述:患病率、危险因素及临床特征
Clin Ther. 2007 Aug;29(8):1548-58. doi: 10.1016/j.clinthera.2007.08.008.